-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on Adient, Lowers Price Target to $13

Benzinga·04/15/2025 12:58:24
Listen to the news
Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $21 to $13.